ITEOS THERAPEUTICS INC (ITOS) Stock Balance Sheet
NASDAQ:ITOS • US46565G1040
Current stock price
10.15 USD
+0.02 (+0.2%)
At close:
10.17 USD
+0.02 (+0.2%)
After Hours:
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | N/A | N/A | N/A | |||
| Cash Equivalents | N/A | 251.18M | 284.80M | 848.50M | 336.30M | |||
| Marketable Securities | N/A | 280.74M | 328.40M | N/A | N/A | |||
| Receivables | 3.69M | 6.50M | 2.40M | 12.10M | 300.00K | |||
| Other Current Assets | 11.00M | 12.00M | 12.70M | 14.10M | 2.90M | |||
| Total Current Assets | 510.00M | 551.00M | 628.30M | 874.70M | 339.50M | |||
| Non-Current Assets | ||||||||
| PPE Net | 9.98M | 11.00M | 6.80M | 7.40M | 1.40M | |||
| Investments And Advances | 160.00M | 101.00M | 118.20M | N/A | N/A | |||
| Other Non-Current Assets | 890.00K | 880.00K | 600.00K | 600.00K | 400.00K | |||
| Total Non-Current Assets | 177.00M | 117.00M | 126.70M | 10.00M | 5.10M | |||
| TOTAL ASSETS | 687.00M | 668.00M | 755.00M | 884.70M | 344.60M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 30.00M | 17.00M | 20.60M | 17.90M | 7.50M | |||
| Accounts Payable | 8.50M | 11.00M | 7.70M | 5.10M | 3.00M | |||
| Other Current Liabilities | 1.40M | 12.00M | 13.80M | 281.10M | 4.50M | |||
| Total Current Liabilities | 40.00M | 40.00M | 42.00M | 304.10M | 15.00M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 56.00M | 52.00M | 49.70M | 27.80M | 6.40M | |||
| Total Non-Current Liabilities | 57.00M | 52.00M | 49.70M | 27.80M | 6.40M | |||
| TOTAL LIABILITIES | 97.00M | 92.00M | 91.70M | 331.90M | 21.40M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -9.78M | 125.00M | 237.30M | 140.60M | -73.90M | |||
| Additional Paid In Capital | 616.00M | 464.00M | 435.70M | 413.20M | 396.40M | |||
| Common Shares | 40.00K | 40.00K | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -16.00M | -13.00M | -9.60M | -1.00M | 600.00K | |||
| Shares Outstanding | 37.00M | 36.00M | 35.70M | 35.50M | 35.00M | |||
| Tangible Book Value per Share | N/A | 16.05 | 18.58 | 15.57 | 9.23 | |||
| Total Shareholders' Equity | 590.00M | 575.00M | 663.30M | 552.80M | 323.20M | |||
| TOTAL LIABILITIES AND EQUITY | 687.00M | 668.00M | 755.00M | 884.70M | 344.60M | |||
| Statistics | ||||||||
| Current Ratio | 12.75 | 13.78 | 14.96 | 2.88 | 22.63 | |||
| Return On Assets (ROA) | -19.57% | -16.86% | 12.81% | 24.25% | -12.59% | |||
| Return On Equity (ROE) | -22.78% | -19.59% | 14.58% | 38.80% | -13.43% | |||
| Return On Invested Capital (ROIC) | N/A | N/A | 13.99% | 33.32% | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | N/A | N/A | 99.98% | N/A | N/A | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexgc) | N/A | N/A | 99.98% | N/A | N/A | |||
All data in USD , ROIC based on taxRate of 0.21